Ad26.RSV.preF completely protects calves from severe respiratory disease induced by bovine RSV challenge
Open Access
- 25 November 2024
- journal article
- research article
- Published by Springer Nature in npj Vaccines
- Vol. 9 (1) , 1-13
Abstract
Vaccination with Ad26.RSV.preF, an Adenoviral serotype 26 vector encoding RSV F protein stabilized in its prefusion conformation, has previously shown to be immunogenic and protective in RSV seropositive adults and immunogenic in seropositive infants. Human and bovine RSV (bRSV) are genetically highly related and share many aspects of pathogenesis, epidemiology and clinical manifestations at young age. As such, infection of calves with bRSV represents a clinically relevant model with high translational value, enabling preclinical evaluation of Ad26.RSV.preF vaccine efficacy in seronegative young animals. Immunization of young calves with Ad26.RSV.preF induced antibodies neutralizing both human and bovine RSV as well as RSV-specific cellular responses. After bRSV challenge, placebo immunized calves showed viral replication in the respiratory tract, and developed fever and lethargy accompanied with severe respiratory distress, resulting in pre-termination of 7/8 calves. In contrast, all Ad26.RSV.preF immunized calves completed the study with only mild clinical symptoms, strongly and significantly diminished viral loads in nasopharynx and lungs, and only minimal lung pathology. Thus, Ad26.RSV.preF is immunogenic in young calves and efficacious in a stringent heterologous bRSV challenge model, demonstrating induction of broadly protective immunity against severe disease.Keywords
This publication has 49 references indexed in Scilit:
- Vaccine-Induced Immunopathology during Bovine Respiratory Syncytial Virus Infection: Exploring the Parameters of PathogenesisJournal of Virology, 2003
- Potential therapeutic implications of new insights into respiratory syncytial virus diseaseRespiratory Research, 2002
- High Mortality Rate Associated with Bovine Respiratory Syncytial Virus (BRSV) Infection in Belgian White Blue Calves Previously Vaccinated with an Inactivated BRSV VaccineJournal of Veterinary Medicine, Series B, 2000
- Interferon gamma production during bovine respiratory syncytial virus (BRSV) infection is diminished in calves vaccinated with formalin-inactivated BRSV.1999
- The effect of formalin-inactivated vaccine on respiratory disease associated with bovine respiratory syncytial virus infection in calvesVaccine, 1999
- A bovine model of vaccine enhanced respiratory syncytial virus pathophysiologyVaccine, 1998
- Identification of a conserved neutralization site in the first heptad repeat of the fusion protein of respiratory syncytial virusArchives of Virology, 1998
- RESPIRATORY SYNCYTIAL VIRUS DISEASE IN INFANTS DESPITE PRIOR ADMINISTRATION OF ANTIGENIC INACTIVATED VACCINE12American Journal of Epidemiology, 1969
- AN EPIDEMIOLOGIC STUDY OF ALTERED CLINICAL REACTIVITY TO RESPIRATORY SYNCYTIAL (RS) VIRUS INFECTION IN CHILDREN PREVIOUSLY VACCINATED WITH AN INACTIVATED RS VIRUS VACCINEAmerican Journal of Epidemiology, 1969
- RESPIRATORY VIRUS IMMUNIZATIONAmerican Journal of Epidemiology, 1969